Restricted accessResearch articleFirst published online 2018-03
Insulin Treatment Cannot Promote Lipogenesis in Rat Fetal Lung in Gestational Diabetes Mellitus Because of Failure to Redress the Imbalance Among SREBP-1,SCAP,and INSIG-1
Gestational diabetes mellitus (GDM) has a higher incidence of neonatal respiratory distress syndrome, and lipogenesis is required for the synthesis of pulmonary surfactants. The aim of this study was to determine the effect of insulin treatment in GDM on the production of lipids in the lungs of fetal rats. GDM was induced by streptozotocin, and insulin was used to manage diabetes. Type II alveolar epithelial cells (AEC II), bronchoalveolar lavage fluid (BALF), and lung tissues of the neonatal rats were sampled for analyses. Insulin treatment could not decrease plasma glucose to normal level at a later gestational stage. Lipids/phospholipids in AEC II, BALF, and lung tissues decreased in GDM, and insulin treatment could not increase the levels; quantitative PCR and western blotting demonstrated a lower level of sterol regulator element-binding protein 1 (SREBP-1), SREBP cleavage-activating protein (SCAP), and insulin-induced gene 1 (INSIG-1) in GDM, but insulin treatment upregulated only SREBP-1. Nuclear translocation of the SREBP-1 protein in AEC II was impaired in GDM, which could not be ameliorated by insulin treatment. These findings indicated that insulin treatment in GDM cannot promote lipogenesis in the fetal lung because of failure to redress the imbalance among SREBP-1, SCAP, and INSIG-1.
Get full access to this article
View all access options for this article.
References
1.
BakinerO., BozkirliE., OzsahinK., SariturkC., and ErtorerE. (2013). Risk factors that can predict antenatal insulin need in gestational diabetes. J Clin Med Res, 5, 381–388.
2.
BarbourL.A., McCurdyC.E., HernandezT.L., KirwanJ.P., CatalanoP.M., and FriedmanJ.E. (2007). Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care, 30, S112–S119.
3.
BecquetO., EI KhabbazK.F., AlbertiC., MohamedD., BlachierA., BiranV., et al. (2015). Insulin treatment of maternal diabetes mellitus and respiratory outcome in late-preterm and term singletons. BMJ Open, 5, e008192.
4.
Bengoechea-AlonsoM.T., and EricssonJ. (2009). A phosphorylation cascade controls the degradation of active SREBP1. J Biol Chem, 284, 5885–5895.
5.
BenhalimaK., RobynsK., Van CrombruggeP, DeprezN., SeynhaveB., DevliegerR., et al. (2015). Differences in pregnancy outcomes and characteristics between insulin- and diet-treated women with gestational diabetes. BMC Pregnancy Childbirth, 15, 271.
6.
BlighE.G., and DyerW.J. (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol, 37, 911–917.
7.
BoghossianN.S., YeungE., AlbertP.S., MendolaP., LaughonS.K., HinkleS.N., et al. (2014). Changes in diabetes status between pregnancies and impact on subsequent newborn outcomes. Am J Obstet Gynecol, 210, 431.e1–e14.
8.
EngleM.J., LanganS.M., and SandersR.L. (1983). The effects of insulin and hyperglycemia on surfactant phospholipid synthesis in organotypic cultures of type II pneumocytes. Biochim Biophys Acta, 753, 6–13.
9.
JanukonytéJ., ParknerT., BruunN.H., LauritzenT., ChristiansenJ.S., and LaursenT. (2015). Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patients. Diabetes Technol Ther, 17, 335–342.
10.
Jian YuanX., ZhaoxiaL., YunC., QinF., YuanyuanC., and DanqingC. (2012). Changes in maternal glucose metabolism after the administration of dexamethasone for fetal lung development. Int J Endocrinol, 2012, 652806.
11.
KoskinenA., LukkarinenH., MoritzN., AhoH., KääpäP., and SoukkaH. (2012). Fetal hyperglycemia alters lung structural development in neonatal rat. Pediatr Pulmonol, 47, 275–282.
12.
KumarR.K., LiW., and O'GradyR. (1995). Maintenance of differentiated phenotype by mouse type 2 pneumocytes in serum-free primary culture. Exp Lung Res, 21, 79–94.
13.
LiS., BrownM.S., and GoldsteinJ.L. (2010). Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A, 107, 3441–3446.
14.
ManiscalcoW.M., FinkelsteinJ.N., and ParkhurstA.B. (1989). Effects of exogenous fatty acids and inhibition of de novo fatty acid synthesis on disaturated phosphatidylcholine production by fetal lung cells and adult type II cells. Exp Lung Res, 15, 473–489.
15.
MasonR.J. (2006). Biology of alveolar type II cells. Respirology, 11, S12–S15.
16.
McGillickE.V., MorrisonJ.L., McMillenI.C., and OrgeigS. (2014). Intrafetal glucose infusion alters glucocorticoid signaling and reduces surfactant protein mRNA expression in the lung of the late-gestation sheep fetus. Am J Physiol Regul Integr Comp Physiol, 307, R538–R545.
17.
MenonR.K., CohenR.M., SperlingM.A., CutfieldW.S., MimouniF., and KhouryJ.C. (1990). Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus—its role in fetal macrosomia. N Engl J Med, 323, 309–315.
18.
NieuwenhuizenM.S., and BarendszA.W. (1987). Various means for the detection of organophosphorous compounds. Int J Environ Anal Chem, 29, 105–118.
19.
OwenJ.L., ZhangY., BaeS.H., FarooqiM.S., LiangG., HammerR.E., et al. (2012). Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase. Proc Natl Acad Sci U S A, 109, 16184–16189.
20.
PetryC.J., OngK.K., HughesI.A., AceriniC.L., FrystykJ., and DungerD.B. (2017). Early pregnancy-associated plasma protein A concentrations are associated with third trimester insulin sensitivity. J Clin Endocrinol Metab, 102, 2000–2008.
21.
RadhakrishnanA., IkedaY., KwonH.J., BrownM.S., and GoldsteinJ.L. (2007). Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A, 104, 6511–6518.
ShiZ., ZhaoC., LongW., DingH., and ShenR. (2015). Microarray expression profile analysis of long non-coding RNAs in umbilical cord plasma reveals their potential role in gestational diabetes-induced macrosomia. Cell Physiol Biochem, 36, 542–554.
24.
XiaoX., and SongB.L. (2013). SREBP: a novel therapeutic target. Acta Biochim Biophys Sin, 45, 2–10.
25.
YellaturuC.R., DengX., CagenL.M., WilcoxH.G., MansbachC.M., SiddiqiS.A., et al. (2009). Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles. J Biol Chem, 284, 7518–7532.
26.
ZhouJ., NiX., HuangX., YaoJ., HeQ., et al. (2016). Potential role of hyperglycemia in fetoplacental endothelial dysfunction in gestational diabetes mellitus. Cell Physiol Biochem, 39, 1317–1328.
27.
ZhouZ., WangF., RenX., WangY., and BlanchardC. (2015). Resistant starch manipulated hyperglycemia/hyperlipidemia and related genes expression in diabetic rats. Int J Biol Macromol, 75, 316–321.
